Author:
Anand Ravi,Hartman Richard D.,Hayes Peggy E.,Gharabawi Marguirguis
Reference4 articles.
1. Enz A, Amstutz R, Hofmann A, Gmelin G and Kelly PH (1990): ENA 713, an acetylcholinesterase-inhibitor with preference for central activity: animal studies. In: Basic, Clinical and Therapeutic Aspects of Alzheimer’s and Parkinson’s diseases. Nagaatsu T, Fischer A and Yoshida M, New York: Plenum Press, pp.425–428.
2. Enz A, Amstutz R, Boddeke H, Gmelin G and Malanowski J (1993): Brain selective inhibition of acetylcholinesterase: a novel approach to therapy for Alzheimer’s desease. Progr Brain Res. 98:431–438.
3. Sramek J J, Anand R, Wardle TS, Irwin P, Hartman RD and Cutler NR (1996): Safety/tolerability trial of SDZENA713 in patients with probable Alzheimer’s disease. Life Sciences 58:1201–1207.
4. SDZENA 713 Investigator’s Brochure (1994): On file at Sandoz Pharmaceuticals Corp.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献